Biopharma Excellence
News & Events
Resource Library
Careers
- Life at PharmaLex
- Current Opportunities
Training

Top Bar

MENUMENU

About UsAbout Us
Our Services
- Discovery / Non-clinical
  - - - Go to Discovery / Non-clinical section >>
  - - - Strategy and Consulting
        Integrated Product Development
        Market Access
        Scientific Advice
        Statistics and Data Sciences
        Toxicology Services
- Clinical Development
  - - - Go to Clinical Development section >>
  - - - Strategy and Consulting
        Clinical Program Development
        Scientific Advice
        Statistics and Data Sciences
      - Regulatory Affairs
        Clinical Trial Applications
        Global Procedure Management
        Health Authority / Agency Interaction
        Regulatory Operations
    - - Pharmacovigilance
        Clinical Trial Safety Support
        Pharmacovigilance Consulting
      - Quality
        GxP Services
        Interim / Contract QA
        Quality Management Systems
        Tech Transfer / Scale-up
- Authorization / Approval
  - - - Go to Authorization / Approval section >>
  - - - Strategy and Consulting
        Market Access
      - Regulatory Affairs
        CMC Services
        Global Procedure Management
        Health Authority / Agency Interaction
        Marketing and Labeling Activities
        Regulatory Operations
        Scientific, Regulatory and Technical Writing
        Statistics and Data Sciences
    - - Pharmacovigilance
        EU QPPV / National QPPV
        Pharmacovigilance Consulting
      - Quality
        Commercialization Readiness
        Commissioning, Qualification, and Validation (CQV)
        GxP Services
        Interim / Contract QA
        PAI Readiness
- Post-approval / Maintenance
  - - - Go to Post-approval / Maintenance section >>
  - - - Strategy and Consulting
        Market Access
      - Regulatory Affairs
        CMC Services
        Global End-to-End Outsourcing
        Global Procedure Management
        Health Authority / Agency Interaction
        Marketing and Labeling Activities
        Mergers and Acquisitions (M&A) Transfers
        Regulatory Operations
        Toxicology Services
      - Pharmacovigilance
        EU QPPV / National QPPV
        ICSR (Individual Safety Case Report) Management
        Literature Monitoring & Screening
        Pharmacovigilance Quality & Compliance
        Signal Management
    - - Quality
        Commissioning, Qualification, and Validation (CQV)
        GxP Services
        Interim / Contract QA
        Quality Management Systems
      - Medical Affairs
        Healthcare Compliance and Medical Approval
- Program Management
  - - - Go to Program Management section >>
      - Program Management
        Global End-to-End Outsourcing
        Global Procedure Management
        Integrated Product Development
        Mergers and Acquisitions (M&A) Transfers
- Featured Expertise
  - - - Industry Expertise
        Biopharmaceuticals
        MedTech Services
    - - Service Expertise
        ATMP / Cell and Gene Therapy
        COVID-19 Support
        GxP Services
        Market Access
        Pharmacovigilance Consulting
        Post-Brexit Regulatory Support
        Statistics and Data Sciences
      - SMARTPHLEX - technology-enabled services
Global ReachGlobal Reach
Contact usContact us
News & Events
Resource Library
Careers
- Life at PharmaLex
- Career Opportunities
Training

Home > News & Events > Industry News Articles > Page 7

Category Archives: Industry News Articles

Nitrosamines – Information for Marketing Authorisation Holders

20th February 2020

iPSpine animation launched at second annual consortium meeting

6th February 2020

PharmaLex expands compliance service offering

5th February 2020

Behavioural Culture in the Workplace

28th January 2020

Vendors in the pharmaceutical industry

16th January 2020

Advertising Compliance for Healthcare Products

9th January 2020

PharmaLex strengthens quality and compliance services

7th January 2020

EU/US Mutual Recognition Agreement for GMP Inspections

2nd January 2020

PharmaLex are in San Francisco for the JP Morgan Healthcare week

20th December 2019

2019: Trending topics in Pharma

18th December 2019

PharmaLex joins forces with Vintura

13th December 2019

Serialisation – New EU Aide Memoire for GDP

11th December 2019

2 3 4

…5 6 7 8 9 …

10 11 12 13 14 15 16 17 18

prev next

Upcoming Webinars

June 28th, 2022

eCTD in Australia: key steps to start a successful submission

08:30 am CET / 4:30 pm AEST

June 28th, 2022

An Introduction to Bayesian adaptive methods in clinical trials

04:00 PM CET

June 30th, 2022

Transforming the drug development process with an integrated strategy

03:00 PM CET

PharmaLex Brings You Biopharma Excellence

Biopharma Excellence is a fusion of three scientific powerhouses, PharmaLex, ERA Consulting and Biopharma Excellence – all under the PharmaLex brand. This global team of scientific, regulatory and commercial professionals provide strategic product development and proactive regulatory services to developers of biopharmaceuticals, cell and gene therapies, monoclonal antibodies (MABs), vaccines and biosimilars.

Visit Website

USEFUL LINKS

Home
Contact us
Imprint
Data Protection
Terms and Conditions

RECENT TWEETS

PharmaLex @PharmaLexGLOBAL·

24 Jun

Milena Shuytsova-Mircheva and Lisa Pascoe latest blog here https://www.pharmalex.com/sponsors-gear-up-for-a-smoother-process-with-ctis-but-must-first-overcome-key-hurdles/ discusses the benefit of the Clinical Trial Information System (CTIS).

💡 Interested in CTIS? Take the Phlexglobal survey to evaluate your preparation https://www.phlexglobal.com/ctis-survey

COVID-19 NEWSLETTER SIGN UP

WHAT OUR CLIENTS SAY

What was especially important to me was their ability to get a team, with the right experience, together so quickly.

Mid-size Biotech
Head of Outsourcing

ISO9001:2015 Logo

Suspicious Emails

We are aware of a number of suspicious emails about recruitment in circulation purporting to be from PharmaLex. Emails sent by PharmaLex will originate from @pharmalex.com. Should you receive an email and are unsure as to its validity, please report it to contact@pharmalex.com.

Many thanks for your understanding.

The PharmaLex Team

Please DO NOT send us event/conference information.
We will not respond and these will be deleted immediately.

Select your state:

Please tick this box to agree to our Privacy Policy

Please tick this box if you agree to periodic updates from PharmaLex.
If you do not wish to receive any communication from us, you may unsubscribe at any time.

Please leave this field empty.

#AskTheExpert #TogetherBEYONDCOVID19

Select your state:

Please tick this box to agree to our Privacy Policy

Please tick this box if you agree to periodic updates from PharmaLex.
You can unsubscribe at any time at data.protection@pharmalex.com

Please leave this field empty.

If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

#TogetherBEYONDCOVID19

We closely monitor developments and updates surrounding the current outbreak of Coronavirus Disease 2019 (COVID-19) from official sources including the World Health Organisation and are following the guidance and direction of the governments and the local authorities. We are taking this situation very seriously and our number one priority is the safety and business continuity for our customers and colleagues. As ever, we will do everything we can to ensure that services are delivered within the required time and the trusted quality PharmaLex is known for

Strategy and Consulting

Strategy and Consulting

Regulatory Affairs

Pharmacovigilance

Quality

Strategy and Consulting

Regulatory Affairs

Pharmacovigilance

Quality

Strategy and Consulting

Regulatory Affairs

Pharmacovigilance

Quality

Medical Affairs

Program Management

Industry Expertise

Service Expertise

Category Archives: Industry News Articles

PharmaLex Brings You Biopharma Excellence